IN2014DN06911A - - Google Patents
Info
- Publication number
- IN2014DN06911A IN2014DN06911A IN6911DEN2014A IN2014DN06911A IN 2014DN06911 A IN2014DN06911 A IN 2014DN06911A IN 6911DEN2014 A IN6911DEN2014 A IN 6911DEN2014A IN 2014DN06911 A IN2014DN06911 A IN 2014DN06911A
- Authority
- IN
- India
- Prior art keywords
- dioleylphosphatidylcholine
- tocopherol
- falls
- range
- blend concentration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012018062 | 2012-01-31 | ||
| PCT/JP2013/051951 WO2013115201A1 (ja) | 2012-01-31 | 2013-01-30 | 非水性液体組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN06911A true IN2014DN06911A (pt) | 2015-05-15 |
Family
ID=48905235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6911DEN2014 IN2014DN06911A (pt) | 2012-01-31 | 2013-01-30 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20150011518A1 (pt) |
| EP (1) | EP2810657B1 (pt) |
| JP (1) | JP2013177372A (pt) |
| KR (1) | KR20150000874A (pt) |
| CN (1) | CN104080478A (pt) |
| CA (1) | CA2861261A1 (pt) |
| EA (1) | EA201491453A1 (pt) |
| IN (1) | IN2014DN06911A (pt) |
| PH (1) | PH12014501689A1 (pt) |
| SG (2) | SG11201404230QA (pt) |
| TW (1) | TW201336526A (pt) |
| WO (1) | WO2013115201A1 (pt) |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9514878D0 (en) * | 1995-07-20 | 1995-09-20 | Danbiosyst Uk | Vitamin E as a solubilizer for drugs contained in lipid vehicles |
| JP2001524958A (ja) * | 1997-04-17 | 2001-12-04 | ジーエス ディベロップメント アクティエボラーグ | 新規な液晶をベースとする生物接着性薬剤送出系 |
| US7731947B2 (en) * | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| JP4496406B2 (ja) | 2003-03-07 | 2010-07-07 | 参天製薬株式会社 | ４−ピリジルアルキルチオ基を置換基として有する新規化合物 |
| WO2006075124A1 (en) * | 2005-01-14 | 2006-07-20 | Camurus Ab | Somatostatin analogue formulations |
| CN1897918A (zh) * | 2003-11-17 | 2007-01-17 | 阿尔萨公司 | 包含两亲性分子作为混悬载体的组合物和剂型 |
| JP4626353B2 (ja) | 2004-02-17 | 2011-02-09 | 参天製薬株式会社 | 置換又は無置換アミノ基を導入した４−ピリジルアルキルチオ基を有する新規環式化合物 |
| GB0412530D0 (en) * | 2004-06-04 | 2004-07-07 | Camurus Ab | Formulation |
| DE602005008247D1 (de) * | 2004-06-04 | 2008-08-28 | Camurus Ab | Flüssige depotformulierungen |
| CA2594718C (en) * | 2005-01-14 | 2012-01-24 | Camurus Ab | Gnrh analogue formulations |
| US9060935B2 (en) * | 2005-01-21 | 2015-06-23 | Camurus Ab | Pharmaceutical lipid compositions |
| JP4585978B2 (ja) | 2005-03-03 | 2010-11-24 | 参天製薬株式会社 | キノリルアルキルチオ基を有する新規環式化合物 |
| JP4834441B2 (ja) | 2005-03-31 | 2011-12-14 | 参天製薬株式会社 | ピリミジニルアルキルチオ基を有する新規環式化合物 |
| US8546326B2 (en) | 2005-06-06 | 2013-10-01 | Camurus Ab | Glp-1 analogue formulations |
| JP4825636B2 (ja) | 2005-09-14 | 2011-11-30 | 参天製薬株式会社 | グルココルチコイド受容体結合活性を有する新規１，２−ジヒドロキノリン誘導体 |
| JP5054996B2 (ja) | 2006-03-14 | 2012-10-24 | 参天製薬株式会社 | グルココルチコイド受容体結合活性を有する新規１，２，３，４−テトラヒドロキノキサリン誘導体 |
| JP4898635B2 (ja) | 2006-11-14 | 2012-03-21 | 参天製薬株式会社 | 置換フェニルアミノ低級アルキル基とエステル構造を導入したフェニル基を置換基として有する新規１，２−ジヒドロキノリン誘導体 |
| CN101600712A (zh) | 2007-01-29 | 2009-12-09 | 参天制药株式会社 | 具有血管新生抑制活性的新型噁二唑衍生物及噻二唑衍生物 |
| US8193187B2 (en) | 2007-05-29 | 2012-06-05 | Santen Pharmaceutical Co., Ltd. | 1,2,3,4-tetrahydroquinoxaline compound with a phenyl group substituent having a sulfonic acid ester structure or a sulfonic acid amide structure introduced therein and having glucocorticoid receptor-binding activity |
| JP2009084274A (ja) | 2007-09-13 | 2009-04-23 | Santen Pharmaceut Co Ltd | 新規１，３，３−トリメチル−７−フェニル−３，４−ジヒドロ−１ｈ−キノキサリン−２−オン誘導体 |
| MY157122A (en) | 2009-07-17 | 2016-05-13 | Santen Pharmaceutical Co Ltd | 2 - [[[2 -[(hydroxyacetyl) amino]- 4 -pyridinyl] methyl]thio]- n -[4 - (trifluoromethoxy) phenyl]- 3 -pyridinecarboxamide benzene-sulfonate, crystal of same, polymorph thereof, and processes for production thereof |
| US8956600B2 (en) * | 2009-08-10 | 2015-02-17 | Taiwan Liposome Co. Ltd. | Ophthalmic drug delivery system containing phospholipid and cholesterol |
-
2013
- 2013-01-30 IN IN6911DEN2014 patent/IN2014DN06911A/en unknown
- 2013-01-30 TW TW102103410A patent/TW201336526A/zh unknown
- 2013-01-30 JP JP2013015164A patent/JP2013177372A/ja active Pending
- 2013-01-30 US US14/375,251 patent/US20150011518A1/en not_active Abandoned
- 2013-01-30 CA CA 2861261 patent/CA2861261A1/en not_active Abandoned
- 2013-01-30 SG SG11201404230QA patent/SG11201404230QA/en unknown
- 2013-01-30 EP EP13744346.1A patent/EP2810657B1/en not_active Not-in-force
- 2013-01-30 WO PCT/JP2013/051951 patent/WO2013115201A1/ja active Application Filing
- 2013-01-30 KR KR20147023427A patent/KR20150000874A/ko not_active Application Discontinuation
- 2013-01-30 SG SG10201606271RA patent/SG10201606271RA/en unknown
- 2013-01-30 CN CN201380007257.3A patent/CN104080478A/zh active Pending
- 2013-01-30 EA EA201491453A patent/EA201491453A1/ru unknown
-
2014
- 2014-07-25 PH PH12014501689A patent/PH12014501689A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG10201606271RA (en) | 2016-09-29 |
| CN104080478A (zh) | 2014-10-01 |
| EP2810657A4 (en) | 2015-07-29 |
| PH12014501689A1 (en) | 2014-10-20 |
| EA201491453A1 (ru) | 2014-12-30 |
| EP2810657B1 (en) | 2016-09-21 |
| JP2013177372A (ja) | 2013-09-09 |
| TW201336526A (zh) | 2013-09-16 |
| SG11201404230QA (en) | 2014-10-30 |
| EP2810657A1 (en) | 2014-12-10 |
| CA2861261A1 (en) | 2013-08-08 |
| US20150011518A1 (en) | 2015-01-08 |
| WO2013115201A1 (ja) | 2013-08-08 |
| KR20150000874A (ko) | 2015-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU348189S (en) | Hitch ball mount | |
| PH12015500115B1 (en) | Glucagon analogues | |
| CL2014002564A1 (es) | Composiciones para tratamiento de agua que comprende un coagulante que contiene aluminio y un polisacarido no derivado natural, en donde la relacion entre el polisacarido y el coagulante es entre 1:10 hasta 1:100; y métodos de uso. | |
| MY170623A (en) | Additive for preparing suede on monocrystalline silicon chip and use method thereof | |
| MA37975A1 (fr) | Inhibiteurs de synthase de glucosylcéramide | |
| IL225734A0 (en) | A ready-to-use medicine vial device including a medicine vial closure, and a medicine vial closure for it | |
| CL2015003738A1 (es) | Formulación líquida estable de amg-416 (velcalcetida) | |
| EP3083925A4 (en) | Stable liquid compositions containing enzymes and peroxides | |
| CA2862669A1 (en) | Application of fluorescent dyes to trace and quantify chemical dosage in industrial wastewater | |
| IN2014MN01553A (pt) | ||
| ZA201504341B (en) | Biodegradable additive concentrate improving the lubricity of aqueous sludges, use thereof and aqueous sludge for drilling | |
| AU352917S (en) | Trailer jack | |
| MX2013008277A (es) | Composicion liquida y acousa de bromfenaco, que tiene efectividad conservadora. | |
| IN2014DN06911A (pt) | ||
| PH12014501307A1 (en) | Liquid activation system | |
| AR097717A1 (es) | Composición gelatinizable con alto contenido de sal para el tratamiento de pozos | |
| GR1008101B (el) | Ποσιμα διαλυματα φυλλικου οξεος | |
| BR112015007885A2 (pt) | composição nutritiva inorgânica de ferro | |
| WO2011092655A3 (en) | Mentha suaveolens essential oil and therapeutic activities thereof | |
| MX369071B (es) | Métodos para prevenir la emulsificación de petróleo crudo en fluidos de tratamiento de pozos. | |
| FENG | The Personalized Society and the Mao Yushi Phenomenon | |
| AU352959S (en) | Trailer jack | |
| AU201215085S (en) | Floatation device | |
| AU352595S (en) | Label for hitch match system | |
| AU345696S (en) | Textiles |